(Q40817597)

24 September 2017

title

Neuroprotective effects of GDNF against 6-OHDA in young and aged rats (English)

1 reference

24 September 2017

Fox CM

1

1 reference

24 September 2017

Gash DM

series ordinal

2

1 reference

24 September 2017

Smoot MK

series ordinal

3

1 reference

24 September 2017

Cass WA

series ordinal

4

1 reference

24 September 2017

publication date

1 March 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

896

1 reference

24 September 2017

issue

1-2

1 reference

24 September 2017

page(s)

56-63

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

24 September 2017

1 reference

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor reverses motor impairment in 16-17 month old rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Dopaminergic neurons protected from degeneration by GDNF gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Ageing and Parkinson's disease: substantia nigra regional selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Functional recovery in parkinsonian monkeys treated with GDNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Practical considerations for the use of the optical disector in estimating neuronal number.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Expression of superoxide dismutase and catalase in rat brain as a function of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Expression of GDNF mRNA in rat and human nervous tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Age-dependent decline of dopamine D1 receptors in human brain: a PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

New stereological methods for counting neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Decreased density of human striatal dopamine uptake sites with age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903270-4

10.1016/S0006-8993(00)03270-4

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference